SCHEDULE: Kynam Capital Discloses 11.01% Stake in Burning Rock Biotech

Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang collectively reported beneficial ownership of 11.01% of Burning Rock Biotech Ltd's American Depository Shares.

Summary

• Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang collectively reported beneficial ownership of 994,883 American Depository Shares (ADSs) of Burning Rock Biotech Ltd.
• This ownership represents 11.01% of the total class of securities.
• The reporting persons share both voting and dispositive power over all 994,883 shares.
• This filing is an Amendment No. 3 to a Schedule 13G, indicating an update to a previously disclosed ownership position.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Burning Rock Biotech Ltd.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership and does not inherently convey strong positive or negative sentiment regarding the issuer's performance or prospects. The continued significant stake by Kynam Capital could be seen as neutral to slightly positive.

Positives

• A significant institutional investor, Kynam Capital Management, maintains a substantial 11.01% stake in Burning Rock Biotech Ltd, which could be interpreted as a signal of continued confidence in the company's long-term prospects.

Negatives

• No specific negative information about Burning Rock Biotech Ltd is disclosed in this beneficial ownership filing.

Risks

• The filing itself does not detail risks related to Burning Rock Biotech Ltd's operations or financial health; it is a disclosure of beneficial ownership.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity.

Key Dates

Keywords

Burning Rock Biotech, Kynam Capital Management, Schedule 13G, Beneficial Ownership, ADSs, Class A Ordinary Share, Institutional Investor, Equity Stake